Annual report pursuant to Section 13 and 15(d)

Segment Disclosures

v3.20.4
Segment Disclosures
 12 Months Ended
Dec. 31, 2020
Segment Reporting [Abstract]  
Segment Disclosures Segment Disclosures
The Company has two reportable segments: EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, sells and rents exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, sells, and rents exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The reportable segments are each managed separately because they serve distinct markets.

The Company evaluates performance and allocates resources based on segment gross profit margin. The Company does not consider net assets as a segment measure and, accordingly, assets are not allocated.

Segment reporting information is as follows:
EksoHealth EksoWorks Total
Year ended December 31, 2020
Revenue $ 8,066  $ 816  $ 8,882 
Cost of revenue 3,219  593  3,812 
Gross profit $ 4,847  $ 223  $ 5,070 
Year ended December 31, 2019
Revenue $ 11,957  $ 1,960  $ 13,917 
Cost of revenue 5,404  1,749  7,153 
Gross profit $ 6,553  $ 211  $ 6,764 

Revenues from one customer of the Company’s EksoHealth segment represented approximately $2,138 of the Company’s consolidated revenues for the year ended December 31, 2019.

Geographic revenue information based on location of customer is as follows:
Years Ended December 31
2020 2019
United States $ 5,945  $ 9,071 
All Other 2,937  4,846 
$ 8,882  $ 13,917